Nurse Practitioner Healthcare Foundation

Continuing Education

Breast Cancer Prevention

Breast Cancer Prevention for Rural Healthcare Providers

This program is sponsored by the Nurse Practitioner Healthcare Foundation in collaboration with the Illinois Critical Hospital Network, University of Illinois, Rockford, and the Michigan Academy of Family Physicians.

It is funded by an unrestricted educational grant from Eli Lilly and Company.

About Breast Cancer Prevention for the Rural Healthcare Provider::
Breast cancer is the most commonly diagnosed cancer among US women and is the second leading cause of cancer-related mortality. A woman's lifetime risk for developing breast cancer, assuming she lives at least 80 years, is 12.5% (1 out of 8)1. The last decade has seen a striking decrease in the overall mortality rate of this disease. While some of this decline can be attributed to better treatment, strategies to prevent breast cancer through risk reduction also play a role. While some risk factors are unavoidable, there are numerous risk factors that are modifiable. There is however a striking difference in this data when viewed from the demographic angle. These numbers are not as improved for the rural resident, who may be more likely poor, of color, and with decreased access to care

Accreditation Statement: This continuing nursing education activity (CEARP #8944, 10/31/09) is approved by the Washington State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Credit: The Nurse Practitioner Healthcare Foundation designates this educational activity for 1.5 contact hours.

Statement of Need: Primary care clinicians, the front line of women's health care particularly in rural settings, must be knowledgeable about breast cancer and the evidence that supports risk reduction for women, especially those at higher risk, in order to provide high quality care, and ultimately continue to impact the decline of breast cancer occurrence.

Intended Audience: This program has been developed for nurse practitioners, nurses, physician assistants, and primary care physicians.

Educational Objectives:
At the conclusion of this activity, the participant should be able to:

Assess breast cancer risk for individual women patients.
Identify patients for whom breast cancer risk reduction is feasible and should be considered.
Describe the reduction in breast cancer risk in older women being treated for osteoporosis withselective estrogen receptor modulators.
Analyze the risk and benefits of selective estrogen receptor modulator in breast cancer prevention.

Faculty:
Steering Committee:	Fiona Shannon, MHS, FNP
	Phyllis Zimmer, MN, FNP, FAAN
	Jerry Price
	Martin Lipsky, MD
Expert Panel:	Katherine Zahasky, MA, ANP;
	Martin Lipsky, MD;
	Richard Nora, MD;
	Elizabeth Peralta, MD, FACS
Reviewers:	Katy Kastle, MSN, FNP;
	Sherril Sego, MN, FNP;
	DeAnne Smith, MSN, FNP

Disclosure Policy: In accordance with the ANCC, NPHF requires that any person who is in a position to control the content of a CNE activity must disclose all financial relationships they have with a commercial interest (an entity that produces an FDA-regulated product).

Steering Committee Disclosures: None

Expert Panel Disclosures:: Zahasky: none. Koenigs: none. Lipsky: Illinois Academy of Family Physicians, sanofi-aventis, Haymarket. Nora: none. Peralta: none.

Reviewer Disclosures: None

Resolution of Conflicts of Interest: To resolve identified conflicts of interest of the faculty and others who were in a position to influence content, the educational content was fully peer-reviewed by a member of the NPHF who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.

Method of Participation: This activity should take approximately 1.5 hours to complete. The participant may either read the article printed in the American Journal for Nurse Practitioners January, 2008, Vol 12_No. 1 or by going to www.nphealthcarefoundation.org continuing education page

Questions re program, evaluation/registration contact: Fiona@nphealthcarefoundation.org

Disclaimer: The content and views presented in this educational activity are those of the faculty and do not necessarily reflect those of the NPHF, the Illinois Critical Access Hospital Network, the University of Illinois, Rockford or the Michigan Academy of Family Physicians. This material has been prepared based on a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter and should not rely solely on the information contained in this educational activity.

Note: This educational activity may contain discussion of published and/or investigational uses of agents that are not yet approved by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should consider the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

This educational activity may discuss complementary/alternative/therapeutic modalities. This discussion does not constitute endorsement of the use of any specific modality in the care of clients.

CEARP #8944—Breast Cancer Prevention for the Rural Healthcare Provider

Registration & Post Test

Breast Cancer Prevention